These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 29128424)

  • 1. The use of synthetic peptides for detection of anti-citrullinated protein antibodies in rheumatoid arthritis.
    Trier NH; Holm BE; Heiden J; Slot O; Locht H; Jensen B; Lindegaard H; Svendsen A; Nielsen CT; Jacobsen S; Theander E; Houen G
    J Immunol Methods; 2018 Mar; 454():6-14. PubMed ID: 29128424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.
    van Heemst J; Trouw LA; Nogueira L; van Steenbergen HW; van der Helm-van Mil AH; Allaart CF; Serre G; Holmdahl R; Huizinga TW; Toes RE; van der Woude D
    Arthritis Res Ther; 2015 Oct; 17():276. PubMed ID: 26437716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-citrullinated protein antibodies in the diagnosis of rheumatoid arthritis (RA): diagnostic performance of automated anti-CCP-2 and anti-CCP-3 antibodies assays.
    Vos I; Van Mol C; Trouw LA; Mahler M; Bakker JA; Van Offel J; De Clerck L; Huizinga TW
    Clin Rheumatol; 2017 Jul; 36(7):1487-1492. PubMed ID: 28578492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis.
    Coenen D; Verschueren P; Westhovens R; Bossuyt X
    Clin Chem; 2007 Mar; 53(3):498-504. PubMed ID: 17259232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a Citrullinated Peptide Panel for Detection of Anti-Citrullinated Protein Antibodies by Enzyme-Linked Immunosorbent Assay.
    Trier NH
    Methods Mol Biol; 2019; 1901():243-253. PubMed ID: 30539584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel bedside test for ACPA: the CCPoint test is moving the laboratory to the rheumatologist's office.
    Zandman-Goddard G; Soriano A; Gilburd B; Lidar M; Kivity S; Kopilov R; Langevitz P; Shoenfeld Y; Agmon-Levin N
    Immunol Res; 2017 Feb; 65(1):363-368. PubMed ID: 27470303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to a strain-specific citrullinated Epstein-Barr virus peptide diagnoses rheumatoid arthritis.
    Trier NH; Holm BE; Heiden J; Slot O; Locht H; Lindegaard H; Svendsen A; Nielsen CT; Jacobsen S; Theander E; Houen G
    Sci Rep; 2018 Feb; 8(1):3684. PubMed ID: 29487382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of the diagnostic and prognostic value of antibodies against chimeric citrullinated synthetic peptides and CCP3/CCP3.1 assays.
    Gómara MJ; Rodríguez J; Bleda MJ; Salvador JP; Sanmartí R; Haro I
    Clin Chem Lab Med; 2018 Jan; 56(2):285-293. PubMed ID: 28850543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do all anti-citrullinated protein/peptide antibody tests measure the same? Evaluation of discrepancy between anti-citrullinated protein/peptide antibody tests in patients with and without rheumatoid arthritis.
    Vander Cruyssen B; Nogueira L; Van Praet J; Deforce D; Elewaut D; Serre G; De Keyser F
    Ann Rheum Dis; 2008 Apr; 67(4):542-6. PubMed ID: 17644546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of synthetic peptides for detection of anti-citrullinated peptide antibodies.
    Trier NH; Holm BE; Slot O; Locht H; Lindegaard H; Svendsen A; Nielsen CT; Jacobsen S; Theander E; Houen G
    Peptides; 2016 Feb; 76():87-95. PubMed ID: 26796582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical Characteristics of a Citrullinated Pro-Filaggrin Epitope Recognized by Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis Sera.
    Trier NH; Holm BE; Slot O; Locht H; Lindegaard H; Svendsen A; Houen G
    PLoS One; 2016; 11(12):e0168542. PubMed ID: 28002483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti -citrullinated peptide antibodies profiling in established rheumatoid arthritis.
    Manca ML; Alunno A; D'Amato C; Bistoni O; Puxeddu I; Gerli R; Migliorini P; Pratesi F
    Joint Bone Spine; 2018 Jul; 85(4):441-445. PubMed ID: 28826660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-cyclic citrullinated peptide antibodies: a comparison of different assays for the diagnosis of rheumatoid arthritis.
    Debaugnies F; Servais G; Badot V; Noubouossie D; Willems D; Corazza F
    Scand J Rheumatol; 2013; 42(2):108-14. PubMed ID: 23126558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic and prognostic value of IgG and IgA anti-citrullinated protein antibodies in patients with early rheumatoid arthritis.
    Sieghart D; Konrad C; Swiniarski S; Haslacher H; Aletaha D; Steiner G
    Front Immunol; 2022; 13():1096866. PubMed ID: 36685579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of a new vimentin-derived ACPA (CCP high sensitive) in patients with rheumatoid arthritis.
    Bertin D; Dubucquoi S; Lakomy D; Deleplancque AS; Desplat-Jégo S
    Immunol Res; 2016 Apr; 64(2):455-60. PubMed ID: 26350265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of synthetic manufactured peptides containing common citrullinated epitopes in rheumatoid arthritis diagnosis.
    Darawshe S; Watad A; Bragazzi NL; Gertel S; Amital H
    Clin Immunol; 2019 Feb; 199():7-11. PubMed ID: 30543920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature.
    Bartoloni E; Alunno A; Bistoni O; Bizzaro N; Migliorini P; Morozzi G; Doria A; Mathieu A; Lotzniker M; Allegri F; Riccieri V; Alpini C; Gabrielli A; Tampoia M; Gerli R;
    Autoimmun Rev; 2012 Sep; 11(11):815-20. PubMed ID: 22394488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of anti-citrullinated protein or peptide antibodies with left ventricular structure and function in rheumatoid arthritis.
    Geraldino-Pardilla L; Russo C; Sokolove J; Robinson WH; Zartoshti A; Van Eyk J; Fert-Bober J; Lima J; Giles JT; Bathon JM
    Rheumatology (Oxford); 2017 Apr; 56(4):534-540. PubMed ID: 27994093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance characteristics of rheumatoid factor and anti-cyclic citrullinated peptide antibody assays may impact ACR/EULAR classification of rheumatoid arthritis.
    Van Hoovels L; Jacobs J; Vander Cruyssen B; Van den Bremt S; Verschueren P; Bossuyt X
    Ann Rheum Dis; 2018 May; 77(5):667-677. PubMed ID: 29363510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
    Schellekens GA; Visser H; de Jong BA; van den Hoogen FH; Hazes JM; Breedveld FC; van Venrooij WJ
    Arthritis Rheum; 2000 Jan; 43(1):155-63. PubMed ID: 10643712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.